ArticleEuropean journal of haematology2021

MCIR1: A patient-derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.

Xiaosheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.